Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | GAA | P10253 | 4/20 | 0.65 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | PLK1 | P53350 | 1/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | HTR7 | P34969 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | ADCY1 | Q08828 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2935942 | 0.89 | ALDH1A1 (0.70) | LMNAALDH1A1GAARAB9AMAPT | |
| SCHEMBL8577031 | 0.83 | LTA4H (0.57) | LMNAALDH1A1RAB9AMAPTLTA4H | |
| SCHEMBL9018906 | 0.83 | LTA4H (0.57) | LMNAALDH1A1RAB9AMAPTLTA4H | |
| SCHEMBL8074583 | 0.82 | ALDH1A1 (0.52) | LMNAALDH1A1GAARAB9AMAPT | |
| SCHEMBL131869 | 0.82 | — | — | |
| SCHEMBL238259 | 0.82 | LTA4H (0.73) | LMNAALDH1A1RAB9AMAPTLTA4H | |
| SCHEMBL13925528 | 0.82 | — | — | |
| SCHEMBL1736339 | 0.82 | LTA4H (0.73) | LMNAALDH1A1RAB9AMAPTLTA4H | |
| SCHEMBL8572071 | 0.82 | LTA4H (0.73) | LMNAALDH1A1RAB9AMAPTLTA4H | |
| SCHEMBL9035286 | 0.82 | ALDH1A1 (0.55) | LMNAALDH1A1GAARAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116891585-A | Preparation method of soluble polyaryletherketone film with low toxicity solvent | 大连中科聚合新材料科技有限公司 | 2023-10-17 | — | — | CN | claimed |
| CN-116891585-A | Preparation method of soluble polyaryletherketone film with low toxicity solvent | 大连中科聚合新材料科技有限公司 | 2023-10-17 | — | — | CN | disclosed |
| WO-2010120859-A1 | BLENDS OF POLYVINYLIDENE FLUORIDE COPOLYMERS WITH SULFONATED POLY(ETHER SULFONES) | ARKEMA INC. (US) | 2010-10-21 | — | — | WO | disclosed |
| US-7803822-B2 | Triazole derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20090105253-A1 | Triazole Derivative and Use Thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-23 | — | — | US | disclosed |
| EP-1867331-A1 | TRIAZOLE DERIVATIVE AND THE USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2007-12-19 | — | — | EP | disclosed |
| US-6166072-A | Amino acid derivatives | ALLELIX NEUROSCIENCE, INC. (CA) | 2000-12-26 | — | — | US | disclosed |
| WO-1999034790-A1 | GLYCINE TRANSPORT INHIBITORS | ALLELIX NEUROSCIENCE, INC. (US) | 1999-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105253-A1 | Triazole Derivative and Use Thereof | F2R, HRH4, F2RL3 | LMNA 2020/4885ALDH1A1 3580/4885GAA 4817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.